Zobrazeno 1 - 9
of 9
pro vyhledávání: '"LIANG BO ZHU"'
Publikováno v:
ARKIVOC, Vol 2005, Iss 15, Pp 81-87 (2005)
Externí odkaz:
https://doaj.org/article/6fb7a104cdb54841a5303f0835247cd9
Autor:
Limin Gao, Dayi Hu, Jianchao Li, Liang Bo Zhu, Wenli Xie, Rongjing Ding, Xiaorong Wang, Qin Tang, Huili Wang
Publikováno v:
Cardiovascular Innovations and Applications, Vol 2, Iss 2, Pp 253-264 (2017)
Aim: To investigate the effect of home-based cardiac rehabilitation on functional capacity, health behavior, and risk factors in patients with acute coronary syndrome in China. Methods: Eighty patients with acute coronary syndrome were enrolled in th
Autor:
YANG ZHOU1, LIANG BO ZHU1, AI FEN PENG2, TAO FANG WANG1, XIN HUA LONG1, SONG GAO1, RONG PING ZHOU3, ZHI LI LIU1 zgm7977@163.com
Publikováno v:
Molecular Medicine Reports. 2015, Vol. 11 Issue 2, p1352-1357. 6p.
Autor:
Guo Mei Zhang, Jia-Ming Liu, Xuan Yin Chen, Zhi Li Liu, Liang Bo Zhu, Xin Hua Long, Zhi Hong Zhang, Shan Hu Huang
Publikováno v:
Molecular Medicine Reports. 12:3543-3548
Our previous study indicated that Aurora-B is involved in osteosarcoma (OS) cell invasion and metastasis; however, the mechanism underlying Aurora-B overexpression in OS remains unknown. In the present study, significantly downregulated let-7i expres
Autor:
Qin Feng Luo, Xuan Yin Chen, Xiao Ping Zhu, Jian Ying He, Liang Bo Zhu, Wei Hong Xi, Xin Hua Long, Zhi Li Liu, Jia Min Liu
Publikováno v:
Tumor Biology. 36:3895-3902
The aim of this study is to investigate the effects of inhibiting Aurora-B on osteosarcoma (OS) cell malignant phenotype, phosphorylation of valosin-containing protein (VCP), and the activity of NF-κB signaling in vitro. The expressions of Aurora-B
Autor:
Ai Fen Peng, Song Gao, Xin Hua Long, Tao Fang Wang, Zhi Li Liu, Yang Zhou, Liang Bo Zhu, Rong Ping Zhou
Publikováno v:
Molecular Medicine Reports. 11:1352-1357
Increasing evidence suggests that fatty acid synthase (FASN) is crucial in the carcinogenesis of various types of tumor. In addition, the phosphatidylinositol 3‑kinase (PI3K)/Akt signaling pathway, which is closely associated with cellular metaboli
Autor:
Zhi Li Liu, Liang Bo Zhu, Ai Fen Peng, Guo Mei Zhang, Xin Hua Long, Zhen Hao Zhong, Heng Wang
Publikováno v:
Molecular Medicine Reports. 10:2967-2972
Pirarubicin is frequently used in chemotherapy against tumors. However, clinical use is severely limited by the development of progressive dose-dependent cardiomyopathy and acquired drug resistance. LY294002 is a commonly used pharmacologic inhibitor
Publikováno v:
ARKIVOC, Vol 2005, Iss 15, Pp 81-87 (2005)
Autor:
XIN HUA LONG, ZHEN HAO ZHONG, AI FEN PENG, LIANG BO ZHU, HENG WANG, GUO MEI ZHANG, ZHI LI LIU
Publikováno v:
Molecular Medicine Reports; 2014, Vol. 10 Issue 6, p2967-2972, 6p